Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasper Almholt

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|October 9, 2004
Reduced metastasis of transgenic mammary cancer in urokinase-deficient miceKasper Almholt, Leif R Lund, Jørgen Rygaard, et al.
Journal of Mammary Gland Biology and Neoplasia|February 9, 2007
Extracellular proteolysis in transgenic mouse models of breast cancerKasper Almholt, Kirsty Anne Green, Anna Juncker-Jensen, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 15, 2014
Sensitive and specific in situ hybridization for early drug discoveryPernille A Usher, Elisabeth D Galsgaard, Kimberly Kruse, et al.
Molecular Cancer Therapeutics|September 16, 2008
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer modelKasper Almholt, Anna Juncker-Jensen, Ole Didrik Laerum, et al.
Clinical & Experimental Metastasis|June 5, 2015
Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPARKasper Almholt, Ole Didrik Lærum, Boye Schnack Nielsen, et al.
The Journal of Investigative Dermatology|March 14, 2008
Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogenKirsty A Green, Kasper Almholt, Michael Ploug, et al.
Thrombosis Research|January 8, 2014
Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway InhibitorLene Hansen, Lars Christian Petersen, Brian Lauritzen, et al.
The Journal of Biological Chemistry|September 19, 2008
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivoIda K Lund, Annika Jögi, Birgitte Rønø, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2022
CTLA4-Ig prevents development of neutralizing antibody formation after continuous treatment with human FVIII in HA ratsGabi Overgaard Øvlisen, Peter Thygesen, Karin Nana Weldingh, et al.
Blood Advances|January 4, 2018
Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cellsSherry Thornton, Harini Raghu, Carolina Cruz, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|October 9, 2004
Reduced metastasis of transgenic mammary cancer in urokinase-deficient miceKasper Almholt, Leif R Lund, Jørgen Rygaard, et al.
Journal of Mammary Gland Biology and Neoplasia|February 9, 2007
Extracellular proteolysis in transgenic mouse models of breast cancerKasper Almholt, Kirsty Anne Green, Anna Juncker-Jensen, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 15, 2014
Sensitive and specific in situ hybridization for early drug discoveryPernille A Usher, Elisabeth D Galsgaard, Kimberly Kruse, et al.
Molecular Cancer Therapeutics|September 16, 2008
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer modelKasper Almholt, Anna Juncker-Jensen, Ole Didrik Laerum, et al.
Clinical & Experimental Metastasis|June 5, 2015
Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPARKasper Almholt, Ole Didrik Lærum, Boye Schnack Nielsen, et al.
The Journal of Investigative Dermatology|March 14, 2008
Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogenKirsty A Green, Kasper Almholt, Michael Ploug, et al.
Thrombosis Research|January 8, 2014
Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway InhibitorLene Hansen, Lars Christian Petersen, Brian Lauritzen, et al.
The Journal of Biological Chemistry|September 19, 2008
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivoIda K Lund, Annika Jögi, Birgitte Rønø, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 25, 2022
CTLA4-Ig prevents development of neutralizing antibody formation after continuous treatment with human FVIII in HA ratsGabi Overgaard Øvlisen, Peter Thygesen, Karin Nana Weldingh, et al.
Blood Advances|January 4, 2018
Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cellsSherry Thornton, Harini Raghu, Carolina Cruz, et al.
Pageof 4